-
Publication Venue For
-
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures..
44:382-390.
2022
-
Head and neck cancer research collaborations between the United States and low- and middle-income countries: 10-year publication analysis..
43:2395-2404.
2021
-
Survival outcomes for head and neck patients with Medicaid: A health insurance paradox..
43:2136-2147.
2021
-
Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma..
43:1629-1640.
2021
-
Postoperative radiotherapy is associated with improved overall survival for alveolar ridge squamous cell carcinoma with adverse pathologic features..
43:203-211.
2021
-
Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease..
42:2505-2515.
2020
-
Advanced head and neck surgery training during the COVID-19 pandemic..
42:1411-1417.
2020
-
Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer..
41:3948-3959.
2019
-
Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma..
41:3056-3063.
2019
-
Salvage laryngectomy and laryngopharyngectomy: Multicenter review of outcomes associated with a reconstructive approach..
41:16-29.
2019
-
Salvage skull base reconstruction in the endoscopic era: Vastus lateralis free tissue transfer..
40:E45-E52.
2018
-
Decreased cancer-independent life expectancy in the head and neck cancer population..
39:1845-1853.
2017
-
ACR appropriateness criteria® nasal cavity and paranasal sinus cancers..
39:407-418.
2017
-
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma..
39:E15-E19.
2017
-
Prognostic value of midtreatment FDG-PET in oropharyngeal cancer..
38:1472-1478.
2016
-
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas..
38:1299-1309.
2016
-
ACR Appropriateness criteria® for nasopharyngeal carcinoma..
38:979-986.
2016
-
Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting..
38 Suppl 1:E1826-E1832.
2016
-
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck..
38:175-182.
2016
-
Primary granulocytic sarcoma of larynx..
37:E38-E44.
2015
-
Comparison of complications in free flap reconstruction for osteoradionecrosis in patients with or without hyperbaric oxygen therapy..
36:1701-1704.
2014
-
Esophageal-subarachnoid fistula: a case of spontaneous tension pneumocephalus in the setting of esophageal cancer..
36:E52-E56.
2014
-
Surgical innovation, industry partnership, and the enemy within..
36:461-465.
2014
-
Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy..
36:215-219.
2014
-
American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer..
36:3-8.
2014
-
Health-related quality of life differences between African Americans and non-Hispanic whites with head and neck cancer..
35:1255-1264.
2013
-
Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers..
35:794-799.
2013
-
Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer..
35:465-466.
2013
-
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia..
34:1681-1703.
2012
-
Chemoradiation for patients with large-volume laryngeal cancers..
34:1162-1167.
2012
-
Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia..
34:1136-1142.
2012
-
Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma..
34:792-796.
2012
-
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil..
34:613-616.
2012
-
Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites..
33:847-855.
2011
-
Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk..
33:650-660.
2011
-
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue..
32:1519-1527.
2010
-
Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids..
32:1209-1216.
2010
-
Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines..
32:700-707.
2010
-
Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma..
32:348-356.
2010
-
Trends in head and neck cancer incidence in Tianjin, China, between 1981 and 2002..
31:175-182.
2009
-
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy..
30:1535-1542.
2008
-
Venous thromboembolism in patients with head and neck cancer after surgery.
2013